诺华因关键药物需求强劲调整盈利展望
· gurufocus.com
2026年10月27日，瑞士制药巨头诺华（NVS）因核心抗癌药和心血管药物需求超出预期，上调了全年核心营业利润预测。
On October 27, 2026, Swiss pharmaceutical giant Novartis NVS raised its full-year core operating profit forecast following robust demand for its key cancer and ...